HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development

Laurent Verkoczy1, Garnett Kelsoe2, Barton F Haynes3

  • 1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Pathology, Duke University School of Medicine, Durham, North Carolina, United States of America.

Plos Pathogens
|May 24, 2014
PubMed
Abstract

No abstract available in PubMed .